ArticleCureus2026
Neurosarcoidosis: When Altered Mental Status Is a Sign of Systemic Disease.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Sarcoidosis is a systemic granulomatous disease of unknown etiology, characterized by a heterogeneous clinical course and the potential to affect any organ. Neurological involvement is rare and often mimics other nervous system disorders, with diagnosis based on the correlation of clinical, radiological, and histological findings, and biopsy of a suspected lesion serving as the definitive diagnostic method. We report the case of a 59-year-old woman, previously independent, who presented with progressive cognitive decline over 4-5 weeks, culminating in the inability to perform basic activities. Based on clinical, laboratory, and imaging findings, including magnetic resonance imaging and FDG-PET, a diagnosis of neurosarcoidosis (NS) was established, and oral corticosteroid therapy was initiated, resulting in significant clinical and imaging improvement. Although histological confirmation was not obtained, the integration of clinical and imaging findings provided consistent support for the diagnosis. This case highlights the importance of early recognition of NS, particularly in subacute presentations with cognitive impairment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.